Comparison the effect of vaginal Misoprostol and vaginal Isoniazid for cervical ripening prior to hysteroscopy procedures
Phase 2
- Conditions
- Abnormal uterine and vaginal bleeding, unspecified.Abnormal uterine and vaginal bleeding, unspecified
- Registration Number
- IRCT2015112821506N4
- Lead Sponsor
- Iran University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- Female
- Target Recruitment
- 100
Inclusion Criteria
postmenopausal women and premenopausal women who have no history of vaginal delivery, not pregnant at the time of examination, no contraindication for receiving prostaglandin , no severe vaginal prolapse , no previous surgery on cervix or cervical incompetence. Exclusion criteria: history of vaginal delivery, pregnancy, severe vaginal prolapse, previous surgery on cervix, history of cervical insufficiency, simultaneous laparoscopy and cervical myoma.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Hysteroscopy entrance without cervical dilatation. Timepoint: During surgery. Method of measurement: Hagar size.
- Secondary Outcome Measures
Name Time Method The number and percent of patients needs for cervical dilatation. Timepoint: During surgery. Method of measurement: Counting.;Maximum Hagar size interring without forces. Timepoint: During surgery. Method of measurement: Hagar.